CBU
CGON icon

CIBC Bancorp USA’s CG Oncology CGON Stock Holding History

CIBC Bancorp USA’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
4,074
+1,100
+37% +$71.9K ﹤0.01% 1485
2026
Q1 		$235K Buy
+2,974
New +$169K ﹤0.01% 1535
2025
Q3 		$240K Buy
+5,957
New +$173K ﹤0.01% 1187

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Bancorp USA's CGON Position: Q2 2026 in Review

CIBC Bancorp USA increased its CG Oncology (CGON) stake by 37% in Q2 2026, buying an estimated $71.9K and bringing the position to 4,074 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

CIBC Bancorp USA first reported a position in CGON in Q3 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • CIBC Bancorp USA held 4,074 shares of CG Oncology worth $331K as of Q2 2026.
  • CIBC Bancorp USA bought 1,100 CG Oncology shares in Q2 2026, an estimated $71.9K.
  • CG Oncology made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1485 holding.
  • CIBC Bancorp USA first reported a position in CG Oncology in Q3 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.